Category: CovidienSyndicate content

Covidien's got a 'new approach' to peripheral arterial disease

October 15, 2013 by Arezu Sarvestani

Covidien releases results from a pair of studies supporting treatment of peripheral artery disease with the EverFlex self-expanding stent combined with directional atherectomy and a drug-coated balloon.

Covidien's got a 'new approach' to peripheral arterial disease

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtech trends: The most talked about device makers in September 2013

October 2, 2013 by Arezu Sarvestani

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

Medtech trends: The most talked about device makers in September 2013

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

Accellent promotes Friedman to president & COO | Personnel Moves

September 26, 2013 by Arezu Sarvestani

Bay State medical device maker Accellent promotes Jeremy Friedman from his role as CFO to president & COO.

fired/hired

 Accellent names new COO, president

Massachusetts medtech manufacturer Accellent Inc. shuffled its C-Suite, promoting Jeremy Friedman from CFO to president and COO of the cardio & vascular business, in addition to his duties as executive vice president.

Ivera lobs another lawsuit at Covidien

September 24, 2013 by Arezu Sarvestani

Ivera Medical claims additional patent infringement by Covidien, filing a 2nd lawsuit over port protection caps.

Ivera lobs another lawsuit at Covidien

California medical device maker Ivera Medical announced a 2nd lawsuit against Covidien (NYSE:COV), this time in a district court in Southern California, claiming infringement of patents for disinfecting caps for medical devices.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Layoffs ahead for Covidien

September 19, 2013 by Brad Perriello

Covidien says it plans to consolidate its manufacturing and distribution operations as part of a global restructuring aimed at saving up to $300 million a year.

Layoffs ahead for Covidien

Covidien (NYSE:COV) said its board of directors authorized a restructuring plan aimed at saving up to $300 million a year by fiscal 2018, with manufacturing and distribution operations slated to be closed. Covidien did not reveal how many layoffs would be involved.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien sued for patent infringement of valve disinfection systems

September 18, 2013 by Arezu Sarvestani

Ivera Medical Corp. says Covidien's line of Kendall Disinfectant Caps infringe on 3 patents for valve cleaning systems.

Covidien sued for patent infringement of valve disinfection systems

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien details fiscal 2014 outlook

September 13, 2013 by Brad Perriello

Covidien issues guidance for its fiscal 2014 sales and earnings.

Covidien details fiscal 2014 outlook

Covidien (NYSE:COV) CFO Charles Dockendorff gave investors a look at what the medical device company expects to see for its fiscal 2014 results.

Speaking at Mansfield, Mass.-based Covidien's annual investor meeting, Dockendorff said net sales for FY2014 are expected to grow between 2% and 5% over fiscal 2013.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp